(ACHC) Acadia Healthcare - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00404A1097

ACHC: Behavioral Healthcare, Inpatient Services, Residential Treatment, Outpatient Care, Recovery Programs

Acadia Healthcare Company, Inc. operates as a leading provider of behavioral healthcare services across the United States and Puerto Rico. The company specializes in developing and operating a diverse network of facilities, including acute inpatient psychiatric hospitals, residential recovery centers, eating disorder treatment facilities, and outpatient behavioral health clinics. These services address a wide range of mental health and addiction recovery needs, catering to individuals, families, and communities. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee, and has grown to become one of the largest behavioral healthcare providers in the U.S., offering evidence-based treatment programs tailored to patient-specific needs.

The companys service portfolio includes intensive inpatient care for acute psychiatric conditions, residential programs for substance abuse and eating disorders, and outpatient services such as counseling and therapy. By integrating medical, therapeutic, and support services, Acadia Healthcare aims to provide comprehensive care pathways for patients at various stages of recovery. Its facilities are designed to offer a continuum of care, ensuring seamless transitions between treatment levels based on patient progress.

Acadia Healthcare has expanded its footprint through strategic acquisitions and organic growth, solidifying its position in the behavioral health sector. The companys operations are supported by a team of healthcare professionals, including psychiatrists, psychologists, nurses, and licensed therapists, who deliver personalized treatment plans. With a focus on improving patient outcomes and addressing the growing demand for mental health services, Acadia Healthcare continues to play a critical role in advancing behavioral healthcare in the U.S.

Based on the provided and , here is a 3-month forecast: - Technical Outlook: The stock is currently trading below its SMA 20, SMA 50, and SMA 200, indicating bearish momentum. The ATR of 1.41 suggests moderate volatility. Over the next 3 months, the stock may face resistance at the SMA 50 level of 29.52, with potential downside risk if it fails to reclaim this level. - Fundamental Outlook: With a P/E ratio of 7.98 and forward P/E of 8.45, the stock appears undervalued relative to its earnings potential. The P/B ratio of 0.66 and P/S ratio of 0.65 further support the undervaluation thesis. However, the RoE of 8.32% is relatively low, which could impact investor sentiment. Over the next quarter, the company may benefit from increased demand for behavioral health services, but operational challenges and macroeconomic conditions could weigh on performance. - 3-Month Forecast: Expect the stock to remain volatile, with potential downside in the near term due to technical resistance levels. However, the companys undervaluation and growth prospects in the behavioral health sector could provide a floor for the stock price. Investors should monitor earnings reports and industry trends for further clarity.

Additional Sources for ACHC Stock

ACHC Stock Overview

Market Cap in USD 2,046m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 1994-03-04

ACHC Stock Ratings

Growth Rating -3.78
Fundamental 28.3
Dividend Rating 0.0
Rel. Strength -68.9
Analysts 4.46/5
Fair Price Momentum 16.85 USD
Fair Price DCF 30.94 USD

ACHC Dividends

No Dividends Paid

ACHC Growth Ratios

Growth Correlation 3m -93.5%
Growth Correlation 12m -84%
Growth Correlation 5y 34%
CAGR 5y 1.63%
CAGR/Max DD 5y 0.02
Sharpe Ratio 12m -1.39
Alpha -77.01
Beta 0.581
Volatility 57.01%
Current Volume 6501.5k
Average Volume 20d 2716.4k
What is the price of ACHC stocks?
As of May 01, 2025, the stock is trading at USD 23.40 with a total of 6,501,529 shares traded.
Over the past week, the price has changed by +10.38%, over one month by -22.82%, over three months by -48.13% and over the past year by -68.35%.
Is Acadia Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Acadia Healthcare is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACHC as of May 2025 is 16.85. This means that ACHC is currently overvalued and has a potential downside of -27.99%.
Is ACHC a buy, sell or hold?
Acadia Healthcare has received a consensus analysts rating of 4.46. Therefor, it is recommend to buy ACHC.
  • Strong Buy: 9
  • Buy: 1
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ACHC stock price target?
According to ValueRays Forecast Model, ACHC Acadia Healthcare will be worth about 18.2 in May 2026. The stock is currently trading at 23.40. This means that the stock has a potential downside of -22.22%.
Issuer Forecast Upside
Wallstreet Target Price 46.4 98.2%
Analysts Target Price 46.4 98.2%
ValueRay Target Price 18.2 -22.2%